MoneyWorks4Me

SMS Lifesciences - Quaterly Results

12 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 828.76 millions, about 16.35% up against Rs. 712.27 millions recorded during the year-ago period.Net profit surges 87.87% to Rs. 62.28  millions  from Rs. 33.15 millions in the quarter ended December 2024.Operating profit surged to 131.30 millions from the corresponding previous quarter of 96.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 828.76 712.27 16.35 2479.43 2136.28 16.06 3000.02 3152.42 -4.83
Other Income 0.61 6.40 -90.47 17.47 15.58 12.13 38.37 28.82 33.14
PBIDT 131.30 96.63 35.88 403.82 251.76 60.40 382.68 292.88 30.66
Interest 19.56 20.45 -4.35 60.40 63.43 -4.78 89.02 50.94 74.75
PBDT 111.74 76.18 46.68 343.42 188.33 82.35 293.66 265.46 10.62
Depreciation 25.64 25.46 0.71 76.35 76.29 0.08 102.54 81.73 25.46
PBT 86.10 50.72 69.76 267.07 112.04 138.37 191.12 183.73 4.02
TAX 23.82 17.57 35.57 80.11 40.73 96.69 60.47 51.55 17.30
Deferred Tax 0.71 2.57 -72.37 2.00 7.73 -74.13 19.94 20.05 -0.55
PAT 62.28 33.15 87.87 186.96 71.31 162.18 130.65 132.18 -1.16
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 15.84 13.57 16.78 16.29 11.78 38.20 12.76 9.29 37.30
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..